Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1,-2 and-3

被引:104
作者
Broek, IV
Asosingh, K
Vanderkerken, K
Straetmans, N
Van Camp, B
Van Riet, I
机构
[1] Free Univ Brussels, Dept Hematol & Immunol, B-1090 Brussels, Belgium
[2] Catholic Univ Louvain, Dept Hematol, B-1200 Brussels, Belgium
关键词
multiple myeloma; CCR2; chemokines; homing; bone marrow;
D O I
10.1038/sj.bjc.6600833
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The restricted bone marrow (BM) localisation of multiple myeloma (MM) cells most likely results from a specific homing influenced by chemotactic factors, combined with the proper signals for growth and survival provided by the BM microenvironment. In analogy to the migration and homing of normal lymphocytes, one can hypothesise that the BM homing of MM cells is mediated by a multistep process, involving the concerted action of adhesion molecules and chemokines. In this study, we report that primary MM cells and myeloma derived cell lines (Karpas, LP-1 and MM5.1) express the chemokine receptor CCR2. In addition, we found that the monocyte chemotactic proteins (MCPs) MCP-1, -2 and -3, three chemokines acting as prominent ligands for CCR2, are produced by stromal cells, cultured from normal and MM BM samples. Conditioned medium (CM) from BM stromal cells, as well as MCP-1, -2 and -3, act as chemoattractants for human MM cells. Moreover, a blocking antibody against CCR2, as well as a combination of neutralizing antibodies against MCP-1, -2 and -3, significantly reduced the migration of human MM cells to BM stromal cell CM. The results obtained in this study indicate the involvement of CCR2 and the MCPs in the BM homing of human MM cells. (C) 2003 Cancer Research UK.
引用
收藏
页码:855 / 862
页数:8
相关论文
共 38 条
[1]  
Amann B, 1998, BRIT J UROL, V82, P118
[2]  
Asosingh K, 2000, CANCER RES, V60, P3096
[3]   Human immunodeficiency virus-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors [J].
Ayehunie, S ;
GarciaZepeda, EA ;
Hoxie, JA ;
Horuk, R ;
Kupper, TS ;
Luster, AD ;
Ruprecht, RM .
BLOOD, 1997, 90 (04) :1379-1386
[4]  
BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P79
[5]   Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line [J].
Biswas, P ;
Delfanti, F ;
Bernasconi, S ;
Mengozzi, M ;
Cota, M ;
Polentarutti, N ;
Mantovani, A ;
Lazzarin, A ;
Sozzani, S ;
Poli, G .
BLOOD, 1998, 91 (01) :258-265
[6]   Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis [J].
Boring, L ;
Gosling, J ;
Cleary, M ;
Charo, IF .
NATURE, 1998, 394 (6696) :894-897
[7]   Laminin-1-induced migration of multiple myeloma cells involves the high-affinity 67 kD laminin receptor [J].
Broek, IV ;
Vanderkerken, K ;
De Greef, C ;
Asosingh, K ;
Straetmans, N ;
Van Camp, B ;
Van Riet, I .
BRITISH JOURNAL OF CANCER, 2001, 85 (09) :1387-1395
[8]   Lymphocyte homing and homeostasis [J].
Butcher, EC ;
Picker, LJ .
SCIENCE, 1996, 272 (5258) :60-66
[9]  
Choi SJ, 2000, BLOOD, V96, P671
[10]   Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays [J].
De Vos, J ;
Couderc, G ;
Tarte, K ;
Jourdan, M ;
Requirand, G ;
Delteil, MC ;
Rossi, JF ;
Mechti, N ;
Klein, B .
BLOOD, 2001, 98 (03) :771-780